Dr. Raphael Nir as Venture Launcher
1. SBH
Dr. Raphael Nir, CEO, Founder and Chairman
It is more accurate to “call” it : Galectin Sciences. It is a JV: SBH Sciences has 50% and Galactin Therapeutics has 50%.
The indication : Liver Fibrosis (NASH) : I assume $5M will advance us to IND.
- Automatics Western Blot capabilities.
We have perform the following (9 case studies with all the data at: http://www.sbhdiagnostics.com/Simple_Western_Studies.asp ):
- Drug Effect On Protein Phosphorylation
- Characterization Of Biotherapeutics
- Drug Response Measurement
- Identification Of Clinical Trial Patient Response
- Monoclonal Antibody Analysis
- Drug Response Time Course
- Calculating Concentration of Unknown Biomarker
- Optimization of Biomarker Recovery
- Knockdown Experiment Using siRNA
2. Woodland Pharmaceuticals
http://woodlandbiosciences.com/Partners.asp
Dr. Raphael Nir, Co-Founder & CEO SBH Sciences
Woodland Biosciences is a strategic alliance between SBH Sciences, Woodland Pharmaceuticals and other partners, doing business as (DBA) Woodland Biosciences.
I assume $5M will advance us to IND for GBM.
We have also another indication : Pancreatic cancer . Similarly, $5M will advance us to IND.
-
Membership Questionnaire
PHARMACEUTICAL
- cytokines
- anti-inflammatory
- anti cancer
Which Business Opportunity relates to your specialty and what direction interests you as a participant in this delegation
- Sell Products : Cytokines & Enzymes- yes
- Find joint venture partners – Yes
- Build new R&D capacity – Yes
- Seek Distributor partner – Yes
What Business opportunity are you seeking in Israel
- Find joint venture partners – Yes
- Seek Distributor partner – Yes
Will you be also interested to meet the following types of Chinese Investors
- Investors/patented technology – Yes
How can your participation in the delegation result in future benefit for Israel
- Participation in the delegation dependent on substantive role for Israeli-based company technology or personnel
- Find joint venture partners – Yes
- Seek Distributor partner – Yes
What are the specific companies or Individuals you would like to meet in Shanghai
SEEKING in China:
- small mid-size Biotechnology companies
- An exist CRO in China to become our Partner
- An exist Life Sciences Distributor as our Partner
Business Proposition by Raphael Nir, PhD, President and CSO
-
SBH Sciences – Background
SBH Sciences has been an innovator in the biotechnology field for 15 years, working with over 100 biotechnology and diagnostic companies. Our diverse diagnostic and drug development activities are fueled by unique products and preclinical services in the cytokine, anti-cancer, and anti-inflammation areas. We provide exemplary customer service and are committed to open communication and on-time-delivery. We support innovation by providing incubator-style support to startup companies and entrepreneur scientists. SBH Sciences is a stimulating workplace and we place an importance on personal growth for our dedicated employees. SBH Sciences’ slogan is “Experience – Innovation – Persistence” and we demonstrate this by supporting the biotechnology industry while maintaining the highest ethical standards. SBH Sciences is located in Natick, MA and is a member of the Massachusetts Biotechnology Council and NEIBC.
All the proposed work will be done exclusively by SBH Sciences scientists or in partnership with our collaborators (see below). There is no minimum contract size and there is no investment requirement at SBH Sciences. However, SBH Diagnostics, Woodland Oncology Services and Cell assay Innovation might consider investment.
SBH Sciences has flexible business arrangement with its customers. We are performing services on fee-for-services, as well as on partnership arrangement.
SEEKING in China: small mid-size Biotechnology companies.
SBH Sciences – Business Proposition
-
Development and Production of Biologics.
SEEKING in China: a small to mid-size Biotechnology companies
-
Providing pre-clinical contract research services, including:
- – Cell-Based Assay (e.g., lead drug optimization for anti-cancer or anti-inflammation small molecules, as well as over 280 cytokines activity assays)
- – Cell Culture (mammalian and insect cells)
- – Protein Purification
- – Analytical HPLC
- – Development of ELISA Kit
- – Biomarkers Analysis (using the Luminex)
- – Biologics formulation studies
- – Biologics stability studies
We are providing our services to very broad range of companies and can tailor our services per specific needs
SEEKING in China: An exist CRO in China to become our Partner.
-
SBH Sciences propose to offer for Distribution in China
- 6 recombinant cytokines (IL-23, BMP-7, MIC-1/GDF-15, CD22, HVEM-Fc and mGramzyme-B), as well as
- 8 recombinant human glycosyltransferase enzymes.
SEEKING in China: An exist Life Sciences Distributor as our Partner.
Our Existing Joint Ventures include:
- SBH Diagnostics
- Woodland Oncology Services
- Cell-Assay Innovations
SBH Sciences in conjunction with SBH Diagnostics, will develop and implement Diagnostics Tests, including:
- evaluating,
- developing and
- sales of CLIA approved Laboratory Developed Tests
SEEKING in China: small to mid-size diagnostics companies.
SBH Sciences in conjunction with Woodland Oncology Services we will provide In-Vivo animal studies mainly related to anti-cancer drug development.
SEEKING in China: small to mid-size Biotechnology companies, can collaborate with an existing CRO
SBH Sciences in conjunction with Cell-Assay Innovations will provide specific kinase cellular screening services and drug development including
- Analysis of Tyrosine Kinases and
- Serine / Threonine Kinases
SEEKING in China: small to mid-size Biotechnology companies.
Leave a Reply